OncoSec Medical Incorporated

OTCPK:ONCS.Q Stock Report

Market Cap: US$805.0k

OncoSec Medical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure9.7yrs

Recent management updates

Recent updates

OncoSec to cut workforce by 45% as part of corporate restructuring

Oct 04

What Type Of Shareholders Make Up OncoSec Medical Incorporated's (NASDAQ:ONCS) Share Registry?

Jan 28
What Type Of Shareholders Make Up OncoSec Medical Incorporated's (NASDAQ:ONCS) Share Registry?

Dosing underway in OncoSec's Tavo combo trial in skin cancer

Jan 08

OncoSec: Undervalued And Continuing To Make Progress

Nov 18

OncoSec drops 11% despite positive data from TAVO + Merck's Keytruda in metastatic melanoma

Nov 09

CEO

OncoSec Medical has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Richard Heller
Member of Scientific Advisory Board12.4yrsno datano data
Walter John Urba
Member of Clinical Advisory Boardno datano datano data
Iacob Mathiesen
Member of Scientific Advisory Board12.4yrsno datano data
Pamela Munster
Member of Clinical Advisory Boardno datano datano data
Axel Hauschild
Member of Clinical Advisory Board10.3yrsno datano data
Soldano Ferrone
Member of Scientific Advisory Board9yrsno datano data
Alain Algazi
Member of Clinical Advisory Board4.8yrsno datano data
Julie Shin
Board Observer4.5yrsno datano data
Robert H.I. Andtbacka
Member of Clinical Advisory Boardno datano datano data
Georgina Long
Member of Clinical Advisory Boardno datano datano data

9.7yrs

Average Tenure

Experienced Board: ONCS.Q's board of directors are considered experienced (9.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/28 18:20
End of Day Share Price 2023/06/28 00:00
Earnings2023/01/31
Annual Earnings2022/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OncoSec Medical Incorporated is covered by 11 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Thomas ShraderBTIG
Raghuram SelvarajuH.C. Wainwright & Co.